By Denny Jacob
Better Therapeutics entered into a rebate agreement with a pharmacy benefit manager.
The prescription digital therapeutics company said the agreement applies to the pharmacy benefit manager's commercial book of business and provides plan participants of the manager the ability to add AspyreRx to their formularies with rebate eligibility.
Better Therapeutics launched AspyreRx in October after receiving authorization from the Food and Drug Administration in July as a treatment for adults with type 2 diabetes.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
February 06, 2024 09:59 ET (14:59 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments